Skip to main content
Year archive

Novartis India Limited. — 2025 filings

All 55 regulatory filings released by Novartis India Limited. (NOVARTIND) in 2025, sourced directly from the official regulator.

55 Filings
2025 Period
2025 filings (55)
Filing Released Lang
Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve The Unaudited Financial Results ....
Regulatory Filings
2025-12-30 English
Intimation of the meeting of the Board of Directors of Novartis India Limited ("the company") and Closure of Trading Window to inter alia, consider and approve the Unaudited Financial Results ....
Regulatory Filings
2025-12-30 English
Company letter dated February 20, 2025 intimating the Stock Exchange on the order received on February 18, 2025 for Service Tax Demand and Penalty for the period October 01, 2014 to June 30, 2017.
Regulatory Filings
2025-11-24 English
Company letter dated February 20, 2025 intimating the Stock Exchange on the order received on February 18, 2025 for Service Tax Demand and Penalty for the period October 01, 2014 to June 30, 2017.
Regulatory Filings
2025-11-24 English
Intimation of newspaper advertisement regarding the publication of unaudited financial results for the quarter and half-year ended September 30, 2025.
Interim / Quarterly Report H1 2025
2025-10-29 English
Integrated Unaudited financial results and Limited Review Report for the Quarter and half-year ended September 30 ,2025.
Regulatory Filings
2025-10-28 English
Outcome of the Board Meeting held on Tuesday, October 28, 2025, to inter alia consider and approve the Financial Statements for the Quarter and Half year ended September 30, 2025.
Regulatory Filings
2025-10-28 English
Certificate in terms of Regulation 74(5) SEBI (Depositories and Participants) Regulations,2018 for the quarter and half-year ended September 2025.
Regulatory Filings
2025-10-13 English
Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2025 ,inter alia, to consider and approve The Meeting of the Board of ....
Regulatory Filings
2025-09-30 English
Pursuant to the "Code of Conduct" to regulate, monitor and report share trading by Designated Person and their immediate relative (''Code'') read with the application provisions of the ....
Regulatory Filings
2025-09-30 English
Intimation of the Voting Results and the Scrutinizer''s Report for the Annual General Meeting of the Company held on Thursday, July, 2025.
Regulatory Filings
2025-08-01 English
Intimation of the proceedings of the 77th Annual General Meeting of the Company held on July 31, 2025, at 11 am IST through video conferencing mode
AGM Information
2025-07-31 English
Intimation of the publication of Financial Results for the quarter ended June 30, 2025 in the Newspaper - Financial Express (English) and Navshakti (Marathi).
Regulatory Filings
2025-07-30 English
Intimation of the approval of the Board of Directors for the Appointment of Cost Auditor for the Financial Year 2025-26
Regulatory Filings
2025-07-29 English
Intimation for the Unaudited Financial Results for the Quarter ended as on June 30, 2025.
Regulatory Filings
2025-07-29 English
Intimation about the Outcome of the Board Meeting held on July 29, 2025, inter alia for the approval of the unaudited Financial Statements for the Quarter ending as on June 30, 2025.
Regulatory Filings
2025-07-29 English
Intimation of the Certificate dated July 10, 2025, received from RTA under Regulation 74(5) of SEBI (DP) Regulations, 2018
Regulatory Filings
2025-07-14 English
Intimation about the 77th Annual General Meeting ("AGM") and Weblink of Anuual Report for F.Y 2024-25 of Novartis India Limited ( "The Company") to the shareholders by way of physical dispatch ....
Regulatory Filings
2025-07-11 English
This intimation is submitted for filing the advertisement post the dispatch of Notice of AGM to the Shareholders.
Regulatory Filings
2025-07-06 English
This intimation is submitted for filing the Business Responsibility and Sustainability Report (''BRSR'') for F.Y 2024-25 which also forms a part of Annual Report of the Company for F.Y 2024-25.
Regulatory Filings
2025-07-04 English
The Annual Report for the Financial Year 2024-25 is sent to the shareholders on July 04, 2025 and BSE is hereby intimated about the same.
Regulatory Filings
2025-07-04 English
Intimation is given that the 77th Annual General Meeting of Novartis India Limited is scheduled to be held on Thursday, July 31, 2025, through Video Conferencing (VC) / Other Audio Visual Means (OAVM)
Regulatory Filings
2025-07-04 English
This Intimation is in relation to the information published in the newspaper to inform the members regarding the proposed 77th Annual General Meeting (''AGM'') of the company to be held ....
Regulatory Filings
2025-07-01 English
The intimation is submitted to update that communication is sent on email to the shareholders regarding the Tax deduction at source on the Dividend if approved at the ensuing Annual General ....
Regulatory Filings
2025-07-01 English
Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 ,inter alia, to consider and approve the Unaudited Financial Results ....
Regulatory Filings
2025-06-30 English
Intimation of the meeting of Board of Directors to be held on Tuesday, July 29, 2025 of the company and the trading window will be closed with effect from Tuesday, July 01, 2025 and will ....
Regulatory Filings
2025-06-30 English
This is for filing the scrutinizer''s report along with the voting results for the Postal Ballot conducted pursuant to the notice dated May 16, 2025.
Regulatory Filings
2025-06-16 English
This is for filing the outcome of the Postal Ballot pursuant to the notice sent on May 16, 2025 to the shareholders, the resolution is deemed to be passed with requisite majority on the ....
Regulatory Filings
2025-06-16 English
Reminder for transfer of shares and unclaimed dividend to Investor Education Protection Fund ("IEPF")
Regulatory Filings
2025-05-30 English
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2025.
Audit Report / Information FY 2025
2025-05-27 English
Intimation of newspaper advertisement published today i.e, May 17, 2025 for completion of e-mailing of Notice of Postal ballot to the Members of the company.
Regulatory Filings
2025-05-17 English
Intimation of Notice of Postal Ballot seeking Consent of the members of the Company.
Regulatory Filings
2025-05-16 English
The intimation is filed for publication of Newspaper Advertisement to provide information to the Shareholders regarding the process for the proposed Postal Ballot and E-voting.
Regulatory Filings
2025-05-14 English
Intimation for fixing the Record Date
Notice of Dividend Amount
2025-05-10 English
The intimation is filed for the submission of newspaper publication for the Financial Results for the Quarter and Financial year ended March 31, 2025.
Regulatory Filings
2025-05-10 English
Intimation of Book Closure date July 24, 2025, to July 31, 2025 (both days inclusive)
Regulatory Filings
2025-05-10 English
Intimation of Book Closure date July 24, 2025, to July 31, 2025 (both days inclusive)
Regulatory Filings
2025-05-10 English
The Board of Directors at their meeting held on May 09, 2025, approved the recommendation of Final Dividend subject to the approval of shareholders at the ensuing AGM.
Regulatory Filings
2025-05-10 English
The Board has approved the Re-appointment of Mr. Sanker Parameswaran (DIN:- 00008187) as an Independent Director for second(02nd) term of five (5) years subject to the approval of the members.
Regulatory Filings
2025-05-10 English
Appointment of Secretarial Auditor for a term of Five (5) consecutive years subject to shareholders approval at the ensuing AGM
Regulatory Filings
2025-05-09 English
Financial Results for the quarter and year ended as on March 31, 2025
Regulatory Filings
2025-05-09 English
Financial Results for the quarter and year ended as on March 31, 2025
Regulatory Filings
2025-05-09 English
Approval of the Financial Statements for the quarter and financial year ended March 31, 2025 along with the Audit Report and declaration of dividend
Regulatory Filings
2025-05-09 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2025-04-23 English
Filing of Certificate in terms of Regulation 74(5) of the SEBI (Depositories & Participants) Regulations, 2018 for the quarter and financial year ended March 31, 2025 received from the ....
Regulatory Filings
2025-04-14 English
We herewith enclose the declaration required to be disclosed under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 received from the promoters ....
Regulatory Filings
2025-04-03 English
Filing of Intimation under Regulation 30 for the receipt of draft tax assessment order by the Company
Regulatory Filings
2025-03-27 English
Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 ,inter alia, to consider and approve The meeting of the Board of ....
Regulatory Filings
2025-03-27 English
The meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 09, 2025 to inter alia consider and approve the Audited Financial Results of the Company for ....
Regulatory Filings
2025-03-27 English
Integrated filing (Financial) for the Quarter and nine months ended December 31 2024.
Regulatory Filings
2025-03-04 English
This is to inform that the Company has received order from Assistant Commissioner of CGST and Central Excise and disclosure is given pursuant to Regulation 30 read with Clause 20 Para A ....
Regulatory Filings
2025-02-20 English
This intimation is in relation to the publication of financial results for the Quarter ended as on December 31, 2024, approved by the Board in their meeting held on January 28, 2025, in ....
Regulatory Filings
2025-01-29 English
We hereby inform that the Board of Directors of the Company at its meeting held today January 28, 2025 have approved the unaudited financials results of the company for the quarter and ....
Regulatory Filings
2025-01-28 English
We hereby inform that the Board of Directors ('Board') of the Company at its Meeting held today i.e. January 28, 2025 inter-alia have considered and approved the Unaudited Financial Results ....
Regulatory Filings
2025-01-28 English
This intimation is filed to submit the compliance certificate issued by MUFG Intime India Private limited(formerly known as Link Intime India Private Limited) dated January 07, 2025 under ....
Regulatory Filings
2025-01-10 English